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2 
Abstract 20 
Decidualization denotes the transformation of endometrial stromal cells into specialized 21 
decidual cells. In pregnancy, decidual cells form a protective matrix around the implanting 22 
embryo, enabling coordinated trophoblast invasion and formation of a functional placenta. 23 
Continuous progesterone signaling renders decidual cells resistant to various environmental 24 
stressors whereas withdrawal inevitably triggers tissue breakdown and menstruation or 25 
miscarriage. Here we show that PLCL1, coding phospholipase C-related catalytically inactive 26 
protein 1 (PRIP-1), is highly induced in response to progesterone signaling in decidualizing 27 
human endometrial stromal cells (HESCs). Knockdown experiments in undifferentiated 28 
HESCs revealed that PRIP-1 maintains basal phosphoinositide 3-kinase / AKT activity, which 29 
in turn prevents illicit nuclear translocation of the forkhead transcription factor FOXO1 and 30 
induction of the apoptotic activator BIM.  By contrast, loss of this scaffold protein did not 31 
compromise survival of decidual cells. PRIP-1 knockdown did also not interfere with the 32 
responsiveness of HESCs to deciduogenic cues, although the overall expression of 33 
differentiation markers, such as PRL, IGFBP1 and WNT4, was blunted. Finally, we show that 34 
PRIP-1 in decidual cells uncouples phospholipase C (PLC) activation from intracellular Ca2+ 35 
release by attenuating inositol trisphosphate (IP3) signaling. In summary, PRIP-1 is a 36 
multifaceted progesterone-inducible scaffold protein that gates the activity of major signal 37 
transduction pathways in the endometrium. It prevents apoptosis of proliferating stromal cells 38 
and contributes to the relative autonomy of decidual cells by silencing PLC signaling 39 
downstream of Gq-protein-coupled receptors. 40 
  41 
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Introduction 42 
Decidualization of the endometrium is indispensible for pregnancy (1). The postovulatory 43 
surge in progesterone and rising cellular cAMP levels during the mid-luteal phase of the cycle 44 
initiate this transformational process (2,3), characterised by the differentiation of stromal cells 45 
in the superficial endometrial layer into specialist decidual cells. Continuous progesterone 46 
signaling is critical for maintaining and enhancing the decidual phenotype throughout 47 
pregnancy (4). In the absence of a viable pregnancy, falling progesterone levels trigger 48 
proteolytic breakdown of the superficial endometrial layer, focal bleeding and menstruation or 49 
menstruation-like bleeding in the case of miscarriage (5-8). Aberrant decidualization has been 50 
implicated in a range of reproductive disorders including endometriosis (9,10), infertility and 51 
recurrent pregnancy loss (11-14). 52 
 53 
Once the luminal endometrial epithelium is breached, migratory decidualizing stromal cells 54 
rapidly encapsulate the invading blastocyst (1,15,16). Emerging evidence indicates that 55 
decidual cells play a critical role in embryo biosensoring and selection (17-19). As pregnancy 56 
unfolds, decidual cells safeguard the conceptus against various stressors. For example, stress-57 
induced signaling through c-Jun N-terminal kinase (JNK) and p38 pathways is selectively 58 
inactivated upon decidualization of human endometrial stromal cells (HESCs) (20). Combined 59 
with the induction of various free radical scavengers, silencing of these stress-signaling 60 
pathways renders decidual cells extraordinarily resistant to oxidative cell death (21-24). 61 
Moreover, circadian oscillations within the endometrium are firmly disabled upon 62 
decidualization, further isolating the implanting blastocyst from the maternal environment (25).  63 
 64 
This study investigates the role of PRIP-1 [Phospholipase C (PLC)-Related, but catalytically 65 
Inactive Protein-1] in decidualizing HESCs. PRIP-1, coded by PLCL1 (phospholipase C-like 66 
1), is structurally homologous to members of the PLC family although it lacks catalytic activity 67 
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(26,27). Like PLC-enzymes, PRIP-1 contains a pleckstrin homology (PH) domain enabling 68 
binding of phosphatidylinositol 4,5-bisphosphate (PIP2) and other phosphoinositides. 69 
However, two key amino-acid mutations within the catalytic domain of PRIP-1 ensure that it 70 
cannot convert PIP2 to inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG) (28). 71 
Consequently, PRIP-1 attenuates IP3-dependent Ca
2+ release from the endoplasmic reticulum 72 
(ER) (29). PRIP-1 also acts as a scaffold protein capable of binding protein phosphatases 1 and 73 
2A (PP1 and PP2A) as well as AKT, a serine/threonine kinase that relays growth factor 74 
signaling downstream of phosphoinositide 3-kinase (PI3K) (30,31). The forkhead box protein 75 
FOXO1 is a key decidual transcription factor downstream of the PI3K/AKT pathway (32-34). 76 
By binding to the progesterone receptor (PGR) and other decidual transcription factors, 77 
FOXO1 drives the expression of several decidual marker genes, including PRL, IGFBP1 and 78 
WNT4 (34-36). However, FOXO1 is also important for cell fate decisions and upregulates the 79 
pro-apototic Bcl-2 family member BIM, coded by BCL2L11, upon withdrawal of progesterone 80 
from decidualizing cultures, triggering cell death (37).  81 
 82 
Gene deletions in mice highlighted the importance of both Prip-1 and its analogue Prip-2 in 83 
reproduction. Double Prip-1/2 deficient mice display reduced litter sizes and exhibit prolonged 84 
intervals between litters. Furthermore, mutant female mice have smaller uteri at puberty, spend 85 
more time in estrous, and have higher gonadotrophin levels (38). PRIP-1 has also been 86 
identified as a progesterone-responsive gene in the human myometrium (39). Taken together, 87 
these findings suggest that PRIP proteins are not only essential for optimal regulation of the 88 
hypothalamic–pituitary–gonadal axis but may also play a role in modulating steroid hormone 89 
responses in target tissues, such as the uterus.  90 
 91 
Here we report that PRIP-1 is strongly induced in decidualizing HESCs in response to 92 
progesterone signaling. We show that this scaffold protein not only modulates the activity of 93 
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the PI3K/AKT/FOXO1 pathway in undifferentiated HESCs but also acts as a chelator of IP3 94 
signaling in decidual cells.    95 
 96 
MATERIALS AND METHODS 97 
 98 
Patient selection and endometrial sampling 99 
The study was approved by the NHS National Research Ethics – Hammersmith and Queen 100 
Charlotte’s & Chelsea Research Ethics Committee (1997/5065). Subjects were recruited from 101 
the Implantation Clinic, a dedicated research clinic at University Hospitals Coventry and 102 
Warwickshire National Health Service Trust. Written informed consent was obtained from all 103 
participants in accordance with the guidelines in The Declaration of Helsinki 2000. Samples 104 
were obtained using a Wallach EndocellTM sampler (Wallach, Trumbull, USA), starting from 105 
the uterine fundus and moving downward to the internal cervical ostium. A total of 43 106 
endometrial biopsies were processed for primary cultures in this study. The average age (± SD) 107 
of the participants was 35.9 ± 4.7 years. In addition, 98 biopsies were used to measure PRIP-1 108 
expression in vivo at mRNA and protein level. All endometrial biopsies were timed between 6 109 
and 10 days after the pre-ovulatory luteinizing hormone (LH) surge. None of the subjects were 110 
on hormonal treatments for at least 3 months prior to the procedure. 111 
 112 
Primary cell culture 113 
HESCs were isolated from endometrial tissues as previously described (40). Purified HESCs 114 
were expanded in culture medium of DMEM/F-12 containing 10% dextran-coated charcoal-115 
treated fetal bovine serum (DCC-FBS), L-glutamine (1%), 1% antibiotic-antimycotic solution, 116 
2 μg / ml recombinant human insulin and 1nM estradiol. Confluent monolayers were 117 
decidualized in DMEM/F-12 containing 2% DCC-FBS (with L-glutamine, excluding insulin 118 
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and estrodiol) with 0.5 mM 8-bromo-cAMP (8-br-cAMP; Sigma-Aldrich, Poole, UK) alone or 119 
in combination with 1 μM medroxyprogesterone acetate (MPA) to induce a decidual 120 
phenotype. Some cultures were also treated with dexamethasone (DEX; 0.1 μM), 121 
dihydrotestosterone  (DHT, 1 μM) or progesterone (P4, 1 μM ). To determine half-life time of 122 
PRIP-1 transcripts, actinomycin D (Sigma-Aldrich) was used at a final concentration of 2 μM 123 
in dimethyl sulfoxide (DMSO). All experiments were carried out before the third passage. 124 
 125 
Transient transfection  126 
Primary HESCs were transfected using a jetPRIME Polyplus transfection kit (VWR 127 
International, Lutterworth, UK). Undifferentiated HESCs were transiently transfected with 50 128 
nM of PRIP-1-siGENOME SMARTpool or siGENOME Non-Targeting (NT) siRNA Pool 1 129 
(Dharmacon, GE Healthcare) for gene knockdown. Transfection studies were performed in 130 
triplicate and repeated on primary cultures from 3 or more different biopsies.  131 
 132 
Immunohistochemistry and immunofluorescence 133 
Paraffin-embedded, formalin fixed endometrial specimens were immunostained for PRIP-1 134 
using the Novolink polymer detection system (Leica) as per manufacturer’s instructions. 135 
Universal LSAB Plus Kits (DAKO, Ely, UK) were used as described previously (41) using 136 
primary antibodies against PRIP-1 (1:750 dilution; Sigma-Aldrich). As a negative control, the 137 
primary antibody was omitted and replaced by the corresponding IgG isotype. For confocal 138 
microscopy, primary HESCs were cultured on glass chamber slides (Thermo Scientific, 139 
Waltham, MA, USA) and transfected with either NT or PRIP-1 siRNA. HESCs were fixed in 140 
4% paraformaldehyde for 10 min, permeabilized with 0.1% Triton X-100 in TBST for 30 min 141 
and blocked in 1% BSA in TBST for 1 hour. Endogenous proteins were stained with rabbit 142 
anti-FOXO1 (2880S, 1:100, Cell Signaling Technology), followed by anti-rabbit FITC (F0205, 143 
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1:500, DAKO). Cells were mounted in Vectashield with DAPI (Vector Labs, Burlingame, CA, 144 
USA) and visualized under a Zeiss LSM 510 META confocal microscope. 145 
 146 
Enzyme-linked immunosorbent assay (ELISA) 147 
HESCs were decidualized and lysed in RIPA buffer with protease inhibitors (cOmplete, Mini, 148 
EDTA-free; Roche, Welwyn Garden City, UK). PRIP-1 levels in whole cell lysates were 149 
determined using a quantitative sandwich ELISA (CusaBio, Wuhan China) according to the 150 
manufacturer’s protocol. The ELISA was validated by measuring PRIP-1 levels following 151 
knockdown and overexpression in cultured human myometrial cells. In spike and recovery 152 
experiments, recovered recombinant PRIP-1 within denatured samples was non-significant 153 
when compared to spiked concentrations (Supplemental Fig. 1). Furthermore, inter- and intra-154 
assay data variance analysis revealed consistent coefficients of variance (CV) below 5%. 155 
Results were derived using a 4-parameter logistic regression analysis and normalised to total 156 
protein concentration as determined by Bio-Rad protein assay (Bio-Rad, Hercules, CA, USA).  157 
 158 
Real-time quantitative (qRT)-PCR 159 
Total RNA was extracted from HESC cultures using RNA STAT-60 (AMS Biotechnology, 160 
Abingdon, UK). Equal amounts of total RNA (1 µg) were treated with DNase and reverse 161 
transcribed using the QuantiTect Reverse Transcription Kit (QIAGEN, Manchester, UK). 162 
Resulting cDNA was used as a template in qRT-PCR analysis. Detection of gene expression 163 
was performed with Power SYBR® Green Master Mix (Life Technologies, Paisley, UK) using 164 
the 7500 Real Time PCR System (Applied Biosystems, Foster City, CA, USA). The expression 165 
levels of the samples were calculated using the ΔΔCT method, incorporating the efficiencies of 166 
each primer pair. Reaction specificity was confirmed by dissociation curve analysis. L19 was 167 
used as a reference gene for normalization. All measurements were performed in triplicate. 168 
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Primer sequences used were as follows: IGFBP1 forward: 5’-cga agg ctc tcc atg tca cca-3’, 169 
IGFBP1 reverse 5’-tgt ctc ctg cct tgg cta aac-3’; L19 forward 5’-gcg gaa ggg tac agc caa-3’, 170 
L19 reverse 5’-gca gcc ggg cgc aaa-3’; PRIP-1 forward 5’-gca gca gca tca tca agg-3’, PRIP-1 171 
reverse 5’-gct gct gaa aga cac ggt tt-3’; PRL forward 5′-aag ctg tag aga ttg agg agc aaa c-3′, 172 
PRL reverse 5′-tca gga tga acc tgg ctg act a-3′ ; WNT4 forward 5’- gca gag ccc tca tga acc t-3’, 173 
WNT4 reverse 5’-cac cgc atg tgt gtc ag-3’. 174 
  175 
Western blot analysis and proteome array  176 
Whole cell protein extracts were prepared by lysing cells in RIPA buffer containing protease 177 
inhibitors (cOmplete, Mini, EDTA-free; Roche, Welwyn Garden City, UK). For nuclear and 178 
cytoplasmic protein fractionation, cells were lysed in Buffer A (10 mM HEPES, 10 mM KCl, 179 
0.1 mM EDTA), centrifuged at 100  g, and the supernatant containing the cytoplasmic fraction 180 
collected. The remaining pellet was then lysed on ice in high salt buffer (5 mM HEPES, 1.5 181 
mM MgCl2, 0.2 mM EDTA, 300 mM NaCl) for 10 min, centrifuged, and the supernatant, 182 
containing the nuclear fraction, retained. Protein yield was measured using the Bradford assay. 183 
Equal amounts of protein were separated by SDS-Polyacrylamide Gel Electrophoresis (SDS-184 
PAGE) and wet transfer onto PVDF membrane (GE Healthcare, Buckinghamshire, UK). 185 
Nonspecific binding sites were blocked by incubation with 5% non-fat dry milk in Tris-186 
buffered saline with 0.05% Tween (TBS-T; 130 mmol / L NaCl, 20 mmol / Tris, pH 7.6 and 187 
0.05% Tween). The primary antibodies used are tabulated in Table 1. Protein complexes were 188 
visualized with ECL Plus chemiluminescence (GE Healthcare). Relative phosphorylation of 189 
26 phospho-kinases was determined by Proteome Profiler Human Phospho-MAPK array kit 190 
(R&D Systems, Minneapolis, MN, USA). The array was performed according to 191 
manufacturer’s specifications using 250 μg total protein lysates. Blots were visualized 192 
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following exposure to chemiluminescent reagents and densitometry performed with individual 193 
phospho-proteins expressed as a percentage of reference dots.   194 
 195 
Confocal imaging of intracellular Ca2+ ([Ca2+]i) oscillations 196 
Decidualizing HESCs were washed in modified Krebs’-Henseleit buffer (composition in 197 
mmol/l: NaCl 133, KCl 4.7, Glucose 11.1, MgSO4 1.2, KH2PO4 1.2, CaCl 2.5, TES 10; pH 7.4 198 
at 37oC) and loaded with 5 μM Fluo-4/AM for 1 hour at room temperature (RT). Cells were 199 
washed and incubated in 2 ml Krebs’-Henseleit buffer. The glass-bottomed Petri dish 200 
containing Fluo-4 loaded cells was secured in a spring-loaded holder in a temperature-201 
controlled environmental chamber on the stage of an inverted microscope (Axiovert 200M) 202 
equipped with an LSM 510 META confocal scanner (Karl Zeiss, Cambridge, UK). Cells were 203 
excited with a krypton/argon laser at 488 nm and emitted light collected above 510 nm through 204 
a 40 oil immersion objective lens. Decidualizing cells transfected with PRIP-1 or non-205 
targeting siRNA were challenged with 5 µM m-3M3FBS or vehicle by direct addition into the 206 
cell-containing Petri dish. Image sequences of fluo-4 fluorescence were recorded for 10 min at 207 
a rate of approximately one frame per second and used as an indication of changes in 208 
[Ca2+]i. Videos were analyzed using LSM image analysis software. Averaged fluorescence 209 
intensity was measured in regions of interest placed over individual cells and expressed as a 210 
fold increase from time 0 (F/F0). Data traces were plotted and peak response, integral (area 211 
under the curve (baseline y=1)) and oscillatory frequency (Hz) were measured.  212 
 213 
Viability and proliferation assays 214 
The number of viable cells was assessed by trypan blue exclusion. Cells were counted on the 215 
Luna cell counter (Logosbio, Annandale, VA, USA), and percentage viability calculated. 216 
Apoptosis was assessed by measurement of the activities of caspase 3/7 using Apo-One 217 
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Homogenous kit (Promega, Madison, WI, USA) according to manufacturer’s guidelines. 218 
Cleavage of a non-fluorescent substrate by caspase 3/7 resulted in fluorescence, measured at 219 
530 nm emission and 490 nm excitation on the PHERAStar FS microplate reader (BMG 220 
Labtect, Ortenberg, Germany). Real-time adherent cell proliferation was determined by the 221 
label-free xCELLigence Real-Time Cell Analyser (RTCA) DP instrument (Roche Diagnostics 222 
GmbH, Basel, Switzerland). HESCs were seeded into 16-well plates (E-plate-16, Roche 223 
Diagnostics GmbH) at a density of 10,000 cells per well and cultured in 10 % DCC-FBS until 224 
reaching ~80 % confluency. The RTCA DP instrument was placed at 37 C in a humidified 225 
environment with 95 % air and 5 % CO2. Individual wells within the E-plate-16 were 226 
referenced immediately and measured first every 15 min for 3 h and then hourly for 100 h. 227 
Changes in cell index were analysed using RTCA Software v1.2. 228 
 229 
Statistical Analysis 230 
Data were analysed with the statistical package Graphpad Prism v6 (Graphpad software Inc, 231 
La Jolla, CA, USA). Unpaired Student’s t-test, Mann-Whitney U test and Pearson’s correlation 232 
were used when appropriate. Statistical significance was assumed at P < 0.05. In the 233 
actinomycin D experiments, PRIP-1 mRNA half-life was calculated using t1/2 = 0.693/k, where 234 
k is the slope derived from a linear equation lnC = lnC0 - kt, and where C is the relative level 235 
of PRIP-1 mRNA in HESCs (42) 236 
  237 
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RESULTS 238 
Induction of PRIP-1 in response to progesterone signaling 239 
PRIP-1 mRNA and protein levels were measured in undifferentiated HESCs and cells 240 
decidualized for 2, 4, or 8 days (Fig. 1A). Decidualization was associated with marked 241 
upregulation of PRIP-1 transcripts with levels rising > 30 fold within 48 hours of 242 
differentiation. The induction of PRIP-1 mRNA was then maintained over the 8-day time-243 
course. By contrast, induction of PRIP-1 protein was more gradual and expression peaked on 244 
day 8 of decidualization (Fig. 1A, lower panel). To define the signaling pathway that drives 245 
PRIP-1 in differentiating HESCs, 3 independent primary cultures were treated with either 8-246 
br-cAMP, MPA or a combination (Fig. 1B). While 8-br-cAMP upregulated PRIP-1 mRNA 247 
levels modestly (~3-fold) after 4 days of treatment, MPA triggered a robust induction (~25-248 
fold). Combined treatment did not yield an additive effect, (Fig. 1B, upper panel) indicating 249 
that induction of PRIP-1 is primarily dependent on progesterone signaling. Regulation at 250 
protein level was somewhat divergent as 8-br-cAMP augmented the induction of PRIP-1 in 251 
response to MPA treatment (Fig. 1B, lower panel). We speculated that the rise in PRIP-1 252 
transcripts in decidualizing cells could, at least partly, reflect increased RNA stability. To test 253 
this hypothesis, undifferentiated and decidualized HESCs were treated with actinomycin D, a 254 
potent transcription inhibitor, for 0.5, 1, 2, 4, or 8 hours. The half-life of PRIP-1 mRNA in 255 
decidualizing cells was non-significantly higher when compared to undifferentiated cells (4.9 256 
versus 3.6 hours, respectively; P > 0.05), indicating that the rise in PRIP-1 is primarily 257 
accounted for by progesterone-dependent transcription. MPA is not only a potent activator of 258 
the progesterone receptor but also exhibits glucocorticoid- and androgen-like activities in 259 
HESCs (43). To determine if PRIP-1 is indeed a progesterone-responsive gene, primary HESC 260 
cultures were treated either with dexamethasone (DEX), dihydrotestosterone (DHT), 261 
progesterone (P4), or MPA. As show in Figure 1D, the induction of PRIP-1 transcripts in 262 
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cultures treated with P4 was comparable to the response with MPA. Notably, DHT but not 263 
DEX triggered a small but significant increase in PRIP-1 expression (P < 0.05). 264 
 265 
Finally, we investigated the expression of PRIP-1 in decidualizing cells upon withdrawal of 266 
deciduogenic signals. Parallel cultures were differentiated with 8-br-cAMP and MPA for 4 267 
days. The decidualization stimulus was then withdrawn for 12, 24, 48 or 72 hours and cultures 268 
harvested for mRNA and protein analyses. Interestingly, PRIP-1 transcript levels fell by 50% 269 
within 24 h after withdrawal of 8-br-CAMP and MPA but then remained stable over the 270 
remainder of the time-course (Fig. 1E). By contrast, PRIP-1 protein levels, measured by 271 
ELISA, declined only modestly (20%) 72 h after withdrawal of 8-br-cAMP and MPA (Fig. 272 
1F). Taken together, the data reveal a significant lag period between the rapid induction of 273 
PRIP-1 transcript levels in response to progestin signaling and the gradual rise in protein levels. 274 
Once induced, PRIP-1 expression is stable and relatively resistant to progesterone withdrawal.  275 
 276 
PRIP-1 expression in luteal phase endometrium 277 
Immunohistochemical analysis of mid-luteal endometrial biopsies revealed that PRIP-1 is 278 
widely expressed in both the epithelial and stromal compartments (Fig. 2A). PRIP-1 279 
immunoreactivity, however, was heterogeneous, especially in the stromal compartment with 280 
some cells staining intensely whereas others showed little expression (Fig. 2A). Mining of the 281 
GEO database (GDS2052) revealed that endometrial PRIP-1 mRNA levels increase markedly 282 
during the early-luteal phase, presumably in response to the rapid rise in post-ovulatory 283 
progesterone levels. Transcript levels then decline and by the late luteal phase are comparable 284 
to proliferative phase endometrium (Fig. 2B). Detailed analysis of timed endometrial biopsies 285 
(LH+6 to +10) indicated that PRIP-1 expression is relatively stable over the peri-implantation 286 
window. Notably, while transcript levels appeared to decline as the cycle progresses to the late 287 
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luteal phase (Spearman’s ρ = -0.1753, P = 0.0812) (Fig. 2C), PRIP-1 protein levels, measured 288 
by ELISA, remained stable (Spearman’s ρ = 0.2421, P = 0.2437)  (Fig. 2D) 289 
 290 
Survival function of PRIP-1 in undifferentiated HESCs.    291 
siRNA-mediated knockdown experiments were performed to examine the function of PRIP-1 292 
in HESCs. Knockdown of this scaffold protein was highly effective; it not only abolished the 293 
induction of PRIP-1 in cells decidualized for 4 days but also lowered basal expression in 294 
undifferentiated HESCS (Fig. 3A). A trypan blue exclusion assay revealed a 28% reduction in 295 
numbers of live cells in undifferentiated HESCs transfected with PRIP-1 siRNA (Fig. 3B). In 296 
parallel, caspase-3 and -7 activities increased by > 3-fold (Fig. 3C). Notably, loss of PRIP-1 297 
did not compromise the viability of differentiating cells treated with MPA and 8-br-cAMP (Fig. 298 
3B & C). Real-time monitoring of cell proliferation over 100 h using microelectronic sensor 299 
technology (xCELLigence) confirmed that PRIP-1 knockdown completely abolished 300 
expansion of undifferentiated HESCs in culture (Fig. 3D). To determine how PRIP-1 exerts its 301 
survival function, total protein lysates from HESCs first transfected with NT or PRIP-1 siRNA 302 
were hybridized to a proteome array. Analysis of the relative phosphorylation levels of 26 303 
kinases revealed that PRIP-1 knockdown selectively inhibits AKT activation (Fig. 3E). 304 
Phosphorylation levels of AKT1 (S473), AKT2 (S474), AKT3 (S472) and pan-AKT (S473, 305 
S474, S472) were reduced by 69%, 59%, 46% and 58%, respectively. We speculated that loss 306 
of AKT activity upon PRIP-1 knockdown would attenuate FOXO1 turnover by promoting 307 
nuclear translocation of this transcription factor (44). Western blot analysis of total protein 308 
lysates provided support for this conjecture and further revealed that the increase in FOXO1 309 
levels in undifferentiated HESCs transfected with PRIP-1 coincided with induction of BIM, a 310 
well-characterized pro-apoptotic FOXO1 target (Fig. 3F) (45). Analysis of fractionated 311 
cytoplasmic and nuclear proteins confirmed that PRIP-1 knockdown increases nuclear FOXO1 312 
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levels (Fig. 3G). However, confocal analysis revealed cellular heterogeneity in this response 313 
with some stromal cells displaying intense nuclear FOXO1 staining whereas other cells did not 314 
(Fig. 3H) 315 
 316 
Expression of decidual markers in response to PRIP-1 knockdown.  317 
We next examined if PRIP-1 is important for the expression of decidual marker genes. When 318 
compared to cell transfected NT siRNA, knockdown of PRIP-1 prior to decidualization reduced 319 
the overall levels of PRL, IGFBP1, and WNT4 transcripts after 4 days of treatment with 8-br-320 
cAMP and MPA. However, only the reduction in WNT4 mRNA was statistically significant 321 
(P < 0.05). Furthermore, basal expression of these 3 genes in undifferentiated cells was 322 
significantly lower (Fig. 4A). Consequently, the overall responsiveness to deciduogenic 323 
signals, determined by fold-induction, was unaffected upon PRIP-1 knockdown; and in case of 324 
PRL even significantly enhanced (Fig. 4B).  325 
 326 
PRIP-1 inhibits PLC-dependent Ca2+ signaling 327 
We hypothesised that induction of PRIP-1 in decidualizing cells could serve to silence PLC-328 
dependent Ca2+ signaling through PIP2 / IP3 chelation. To test this conjecture, primary HESCs 329 
were transfected with either non-targeting (NT) or PRIP-1 siRNA prior to decidualization for 330 
4 days. The cultures were then loaded with the fluorescent Ca2+ indicator Fluo-4 and challenged 331 
with the PLC activator m-3M3FBS or vehicle (DMSO). Decidualizing cultures transfected with 332 
NT siRNA displayed minimal [Ca2+]i oscillations in response to PLC activation. By contrast, 333 
cells transfected with PRIP-1 siRNA exhibited robust and sustained [Ca2+]i fluxes over the 334 
entire recording (Fig. 5A). Analysis of 4 independent cultures revealed PRIP-1 knockdown 335 
resulted in 2-fold increase in oscillation frequency, 2-fold increase in peak fluorescence, and 336 
3-fold increase in the area under the curve (Fig. 5B) in response to PLC activation. These results 337 
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support the conjecture that the sustained induction of PRIP-1 in decidualizing HESCs acts to 338 
sequester phosphoinositides and to limit [Ca2+]i release.  339 
  340 
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DISCUSSION 341 
By activating its cognate nuclear receptor, progesterone controls the expression of numerous 342 
genes that encode membrane-bound receptors and intermediates in various signal transduction 343 
pathways in differentiating HESCs (46,47). Consequently, progesterone transforms the 344 
processing of cellular signals and environmental cues upon decidualization. For example, 345 
knockdown of PGR is sufficient to inhibit activation of the WNT/beta-catenin, TGF/SMAD, 346 
and STAT pathways in decidualizing cells (46). Progesterone also induces MAPK phosphatase 347 
1 (MKP-1/DUSP1) (48), which in turn disables JNK and p38 stress-responsive pathways in 348 
decidualizing HESCs (49). We now report that progesterone strongly up-regulates PRIP-1 349 
expression in HESCs. Once induced, this scaffold protein accumulates in decidualizing HESCs 350 
and levels remain relatively stable even upon withdrawal of progestins.  351 
 352 
Unexpectedly, knockdown experiments demonstrated that basal PRIP-1 levels are critical for 353 
survival of undifferentiated HESCs. This anti-apoptotic function of PRIP-1 is predicated on its 354 
ability to regulate the activity of AKT, either by facilitating interaction with upstream kinases 355 
or, conversely, by sequestering AKT phosphatases such as PP2A (50). AKT-dependent 356 
phosphorylation of FOXO1 leads to its nuclear export, ubiquitination mediated by E3 ligases 357 
such as SKP2 and MDM2, and proteasomal degradation (51,52). PRIP-1 deficiency in HESCs 358 
selectively reduced AKT activity by more than 50%, which was sufficient to increase nuclear 359 
FOXO1 levels and activate the pro-apoptotic machinery. Notably, loss of cell viability upon 360 
PRIP-1 knockdown was only partial. It is increasingly appreciated that primary HESC cultures 361 
consist of distinct communities of cells, including clonogenic mesemchymal, mature progeny, 362 
perivascular SUSD2-positive cells, and senescent fibroblasts (53-56). Hence, it is not 363 
inconceivable that some but not all subpopulations of HESCs are dependent on PRIP-1 for 364 
survival, although this conjecture requires further testing.   365 
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 366 
PRIP-1 knockdown did not interfere with the responsiveness of the HESCs to deciduogenic 367 
cues. This is not surprising as FOXO1 accumulates in the nuclei of differentiating HESCs 368 
where it binds other decidual transcription factors, including PGR, HOXA11 and C/EBP, 369 
resulting in formation of transcriptional complexes that activate differentiation genes, 370 
including WNT4, PRL and IGFBP1 (32,34,35,57). Unexpectedly, basal expression levels of 371 
WNT4, PRL and IGFBP1 were markedly lower in undifferentiated HESCs transfected with 372 
PRIP-1 siRNA. A parsimonious explanation for this intriguing observation is that loss of PRIP-373 
1 triggers apoptosis in a subpopulation of HESCs, characterized by relatively high basal 374 
expression of decidual markers. Notably, knockdown of FOXO1 in decidualizing HESC 375 
cultures completely eliminates apoptosis upon progestin withdrawal (37,44), indicating that the 376 
ability of FOXO1 to switch between apoptosis and differentiation targets is dependent on 377 
progesterone signaling.   378 
 379 
Upregulation of PRIP-1 in decidual cells may primarily serve to silence PLC signaling 380 
downstream of Gq-protein-coupled receptors. Upon implantation, decidual cells form a 381 
nutritive matrix for trophoblast invasion that is relatively autonomous and resistant to 382 
potentially harmful maternal inputs. Various mechanisms underpinning decidual resistance 383 
have been described, including silencing of circadian oscillations (25), massive increase in 384 
cellular ROS-scavenging potential (21,23), global cellular hypo-SUMOylation (3,22), and the 385 
aforementioned inhibition of stress-responsive pathways (22,58). These adaptations ensure 386 
unimpeded progesterone signaling even under conditions of intense tissue remodelling and 387 
changing oxygen tension at the feto-maternal interface (22). The trophic function of decidual 388 
cells depends on acquisition of a secretory phenotype, which in turn requires rapid expansion 389 
of the ER in differentiating HESCs. Ergo, differentiating HESCs mount a physiological 390 
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unfolded protein response (UPR) characterised by up-regulation of various molecular 391 
chaperones, including protein disulfide isomerase (PDI), BIP (GRP78), endoplasmic 392 
oxidoreductin-1α (ERO1α), and calnexin (17).  We now show that, by chelating IP3, PRIP-1 393 
limits Ca2+ release from the expanding ER, which arguably safeguards decidual cells against 394 
excessive Ca2+ accumulation in the mitochondrial matrix, permeabilization of the 395 
mitochondrial outer membrane and subsequent apoptosis (59). Interestingly, PRIP-1 also 396 
inhibits autophagosome formation by binding to microtubule-associated protein 1 light chain 397 
3 (LC3), a key initiator of the autophagy pathway (60). The importance of these pathways in 398 
the endometrium is underscored by recent observations demonstrating that ER stress and 399 
autophagy in decidual cells mediate recognition and rejection of developmentally 400 
compromised human embryos (17). Arguably, silencing PLC signaling downstream of Gq-401 
protein-coupled receptors may also enhance the biosensoring function of decidual cells by 402 
restricting signaling to discrete embryonic cues.  403 
 404 
In conclusion, PRIP-1 is a versatile progesterone-inducible scaffold protein in the 405 
endometrium. Our data suggest that the function of PRIP-1 switches from amplifying AKT 406 
activity in proliferating HESCs to inhibiting PLC signaling downstream of Gq-protein-coupled 407 
receptors in decidual cells. The role of PRIP-1 in regulating the responses of decidual cells to 408 
embryonic and trophoblast signals warrants further investigation.  409 
  410 
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FIGURE LEGENDS 602 
 603 
Figure 1. Progesterone regulates PRIP-1 expression in HESCs.  (A) PRIP-1 transcript and 604 
protein levels were measured in undifferentiated HESCs and cells decidualized with 8-br-605 
cAMP and MPA for 2, 4, or 8 days. The upper panel shows fold induction of PRIP-1 mRNA 606 
(mean ± SEM) in 3 independent primary cultures relative to expression in undifferentiated 607 
cells. Total protein lysates from parallel cultures were subjected to Western blotting (lower 608 
panel). β-Actin served as a loading control. (B) Primary HESC cultures were treated with either 609 
8-br-cAMP, MPA or a combination for 96 hours. The upper panel shows the relative increase 610 
in PRIP-1 mRNA levels (mean ± SEM) compared to vehicle-treated undifferentiated HESC 611 
cultures established from 3 biopsies. The lower panel shows the corresponding protein levels, 612 
determined by Western blotting. β-Actin served as a loading control. (C) Primary cultures (n = 613 
3) remained undifferentiated or were decidualized for 96 h prior to treatment with 2 μM 614 
actinomycin D. RNA was extracted at the indicated time points and subjected to qRT-PCR 615 
analysis. (D) Primary HESCs isolated from 3 different biopsies were treated with 616 
dexamethasone (DEX), dihydrotestosterone (DHT), progesterone (P4), MPA or vehicle 617 
(control). Total RNA was harvested 96 hours later and subjected to qRT-PCR analysis. The 618 
data show induction of PRIP-1 transcripts (mean ± SEM) relative to control cells. (E) PRIP-1 619 
transcripts were measured following withdrawal of MPA for the indicated time-points in 3 620 
separate cultures first decidualized with 8-br-cAMP and MPA for 96 h. PRIP-1 mRNA levels 621 
were normalised to the level of expression in undifferentiated cells (dotted line). (F) Total 622 
protein lysates were harvested from parallel cultures PRIP-1 protein levels determined by 623 
ELISA.  * denotes P < 0.05, ** P < 0.01 624 
 625 
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Figure 2. PRIP-1 expression in mid-luteal endometrium.  (A) Immunohistochemistry of mid-626 
luteal endometrial biopsies demonstrates heterogeneous expression of PRIP-1 in both stromal 627 
and epithelial cells. (B) Comparison of endometrial PRIP-1 transcripts, expressed in arbitrary 628 
units (A.U.), in proliferative, early-, mid-, and late-secretory endometrium. The data were 629 
derived from in silico analysis of publicly available microarray data (GEO Profiles; ID: 630 
GDS2052). * denotes P < 0.05. (C) PRIP-1 transcript levels were measured by qRT-PCR in 631 
73 endometrial biopsies obtained between 6 and 10 days after the LH surge (LH+). (D) PRIP-632 
1 protein levels were measured, in triplicate, in 25 whole endometrial samples by ELISA.. 633 
Dotted lines represent 95% confidence intervals. 634 
 635 
Figure 3.  PRIP-1 is a survival factor in undifferentiated HESCs. (A) Three independent 636 
primary cultures were transfected with either non-targeted (NT) or PRIP-1 siRNA. After 48 637 
hours, some cultures were decidualized for 96 h whereas others remained untreated. PRIP-1 638 
mRNA and protein levels were measured in parallel cultures by qRT-PCR (upper panel) and 639 
Western blot (lower panel), respectively. Transcript levels were normalized to expression in 640 
undifferentiated cells transfected with NT siRNA. *** denotes P < 0.001. (B) Cell viability as 641 
measured by trypan blue exclusion assay in 3 independent primary cultures first transfected 642 
with either NT or PRIP-1 siRNA. Following transfection, the cultures remained either 643 
untreated or were decidualized for 96 h. Data normalised to un-transfected control (dotted line) 644 
(C) In parallel experiments, caspase 3/7 activity was measured and expressed in fluorescent 645 
intensity units (F.I.U). The data represent mean (± SEM) activity in 3 independent cultures. ** 646 
denotes P < 0.01. (D) Real-time monitoring of the growth of undifferentiated HESCs over 100 647 
h following transfection with NT or PRIP-1 siRNA. (E) Protein lysates from undifferentiated 648 
HESC transfected with either NT or PRIP-1 siRNA were subjected to Proteome Profiler MAPK 649 
array membranes and analysed by densitometry. * denotes P < 0.05 and *** P < 0.01. (F) 650 
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Western blot analysis of total protein lysates from undifferentiated HESCs 48 h following 651 
transfection with either NT or PRIP-1 siRNA. (G) Nuclear accumulation of FOXO1 was 652 
confirmed by Western blot analysis of cytoplasmic and nuclear cell fractions. VINCULIN and 653 
LAMIN A/C confirmed enrichment of the cytoplasmic and nuclear proteins, respectively. (H) 654 
Confocal microscopy showing FOXO1 immunoreactivity in primary HESCs transfected with 655 
either NT or PRIP-1 siRNA. Arrow heads indicate cells characterized by marked nuclear 656 
FOXO1 accumulation.  657 
 658 
Figure 4. PRIP-1 blunts the overall expression of differentiation markers in decidualizing 659 
HESCs (A) Three independent primary HESCs were first transfected with NT or PRIP-1 660 
siRNA. The cultures then remained untreated or were decidualized with 8-br-cAMP and MPA. 661 
The data shows relative expression (mean ± SEM) of decidual marker genes. (B) The same 662 
data expressed as fold-induction in transcript level relative to the basal levels in 663 
undifferentiated cells transfected with NT or PRIP-1 siRNA. * denotes P < 0.05 and *** P < 664 
0.01. 665 
 666 
Figure 5. PRIP-1 blocks PLC-dependent Ca2+ signaling in decidual cells. (A) HESCs 667 
cultured in glass bottomed petri-dishes were transfected with NT (left panel) or PRIP-1 (right 668 
panel) siRNA and decidualized for 4 days. Cells were then loaded with 5 μM Fluo-4-AM and 669 
challenged with 5μM m-3M3FBS or vehicle (data not shown) at the indicated time-point. 670 
Cytosolic fluorescence recorded by confocal microscopy over 10 min was used as an index of 671 
[Ca2+]i. Traces showing fluorescence within individual cells, transfected either with NT (left 672 
panel) or PRIP-1 siRNA (right panel) are expressed as a fold increase over fluorescence at 673 
time-0 (F/F0). Data were obtained from 4 independent cultures. (B) Traces were analysed to 674 
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assess the peak changes in fluorescence, the integral, and oscillation frequency (Hz). Data show 675 
mean ± SEM. **** denotes P < 0.0001. 676 






Supplemental Fig. 1.  Validation of PRIP-1 Sandwich ELISA. For generation of the PRIP-
1 standard curve (A), supplied recombinant PRIP-1 was diluted and assayed exactly as per 
ELISA manufacturer’s instructions (CusaBio, Wuhan, China). (B) To validate the ELISA, 
cultured primary myometrial cells were transfected with either 50 nM PRIP-1 siRNA, non-
targeting (NT) scrambled siRNA controls, or 1 µg plasmid DNA encoding the PRIP-1 gene. 
PRIP-1 plasmid DNA was purified from ready-transformed bacterial glycerol stocks 
containing the cDNA for human PRIP-1 in a pCR4-TOPO plasmid (Thermo Scientific, Hemel 
Hempstead, UK). Cells were transfected via an Amaxa™ basic Nucleofector™ kit as per 
manufacturer’s instructions (Lonza, Basel, Switzerland), lysed and assayed for PRIP-1 content. 
In spike and recovery experiments, recombinant PRIP-1 was spiked into denatured (30 min, 
100oC) myometrial cell lysates and recovered PRIP-1 levels determined. Spike and recovery 
experiments revealed no significant differences. Data are mean ± SEM., n=3. 
 
Table 1: Primary Antibodies   
Protein Target Manufacturer  Dilution 
PRIP-1 Sigma- Aldrich (HPA031849) WB 1:500 Immunohistochemistry 1:750 
AKT Cell Signaling Technology (4691) WB 1:1000 
p-AKT (Ser473) Cell Signaling Technology (4060) WB 1:1000 
FOXO1A Cell Signaling Technology (2880) WB 1:1000 
BIM Cell Signaling Technology (2933) WB 1:1000 
VINCULIN Abcam (ab18058) WB 1:1000 
LAMIN A/C Santa-Cruz Biotechnology (sc-7292) WB 1:500 
β-ACTIN Abcam (ab8226) WB 1:10,000 
 
 
 
 
